Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138906837> ?p ?o ?g. }
- W3138906837 abstract "Acute myeloid leukemia (AML) is a heterogeneous malignant disorder of hematopoietic progenitor cells characterized by the accumulation of several genetic and epigenetic mutations. Despite the progressive understanding of the molecular heterogeneity of the disease, the survival rate of patients older than 60 years old remains poor. Therefore, it is necessary to develop an effective treatment strategy for those patients in order to beat the disease and improve life quality. Reversible phosphorylation has been widely studied over the last years, and the deregulation of kinases and phosphatase have been verified to have a huge impact in leukemogenesis. Inactivation of the tumor-suppressor protein phosphatase 2A (PP2A) is frequent in AML patients, constituting a promising target for cancer therapy. There are several PP2A inactivation mechanisms. However, overexpression of SET or cancerous inhibitors of PP2A, both endogenous inhibitors of PP2A, are recurrent events in AML patients, leading to the inactivation of the phosphatase PP2A. Preclinical studies show that PP2A reactivation using PP2A-activating drugs (PADs) manage to stop the development of the disease, and its combination with conventional chemotherapy and tyrosine kinase inhibitors have a synergistic cytotoxic effects. Recent studies have demonstrated that specifically activation of PP2A subunits, target crucial pathogenic drivers, increasing the efficacy of conventional treatments and opening new possibilities for personalized treatment in AML patients, especially in cases of PP2A deregulation. Here, we review the role of PP2A in AML as well as its drugable options." @default.
- W3138906837 created "2021-03-29" @default.
- W3138906837 creator A5016683229 @default.
- W3138906837 creator A5022376380 @default.
- W3138906837 creator A5065861193 @default.
- W3138906837 creator A5071505226 @default.
- W3138906837 date "2021-03-24" @default.
- W3138906837 modified "2023-09-24" @default.
- W3138906837 title "The Key Role of the Phosphatase PP2A in the Development of Acute Myeloid Leukemia" @default.
- W3138906837 cites W1255676896 @default.
- W3138906837 cites W151043947 @default.
- W3138906837 cites W1809486093 @default.
- W3138906837 cites W1819171550 @default.
- W3138906837 cites W1964241796 @default.
- W3138906837 cites W1965006511 @default.
- W3138906837 cites W1965418027 @default.
- W3138906837 cites W1968076808 @default.
- W3138906837 cites W1971335607 @default.
- W3138906837 cites W1971626394 @default.
- W3138906837 cites W1972236331 @default.
- W3138906837 cites W1974894246 @default.
- W3138906837 cites W1975748957 @default.
- W3138906837 cites W1978756702 @default.
- W3138906837 cites W1981083415 @default.
- W3138906837 cites W1984551975 @default.
- W3138906837 cites W1985911963 @default.
- W3138906837 cites W1987474302 @default.
- W3138906837 cites W1988862655 @default.
- W3138906837 cites W1996773578 @default.
- W3138906837 cites W1997996290 @default.
- W3138906837 cites W1998334997 @default.
- W3138906837 cites W1999327797 @default.
- W3138906837 cites W2000096604 @default.
- W3138906837 cites W2003060606 @default.
- W3138906837 cites W2005488000 @default.
- W3138906837 cites W2013713190 @default.
- W3138906837 cites W2016885254 @default.
- W3138906837 cites W2017958579 @default.
- W3138906837 cites W2018872127 @default.
- W3138906837 cites W2021029116 @default.
- W3138906837 cites W2021359328 @default.
- W3138906837 cites W2021635600 @default.
- W3138906837 cites W2029544039 @default.
- W3138906837 cites W2031090484 @default.
- W3138906837 cites W2031380298 @default.
- W3138906837 cites W2032791659 @default.
- W3138906837 cites W2036495494 @default.
- W3138906837 cites W2037250704 @default.
- W3138906837 cites W2040802938 @default.
- W3138906837 cites W2047013481 @default.
- W3138906837 cites W2051890221 @default.
- W3138906837 cites W2053645860 @default.
- W3138906837 cites W2054086725 @default.
- W3138906837 cites W2054177883 @default.
- W3138906837 cites W2056937655 @default.
- W3138906837 cites W2061243113 @default.
- W3138906837 cites W2067890488 @default.
- W3138906837 cites W2070516871 @default.
- W3138906837 cites W2070544692 @default.
- W3138906837 cites W2071183768 @default.
- W3138906837 cites W2071645343 @default.
- W3138906837 cites W2071779883 @default.
- W3138906837 cites W2074085971 @default.
- W3138906837 cites W2077038948 @default.
- W3138906837 cites W2077113458 @default.
- W3138906837 cites W2078143617 @default.
- W3138906837 cites W2079975524 @default.
- W3138906837 cites W2083459920 @default.
- W3138906837 cites W2083832170 @default.
- W3138906837 cites W2092869304 @default.
- W3138906837 cites W2110138808 @default.
- W3138906837 cites W2110909186 @default.
- W3138906837 cites W2111614147 @default.
- W3138906837 cites W2112049656 @default.
- W3138906837 cites W2112135110 @default.
- W3138906837 cites W2114625809 @default.
- W3138906837 cites W2115143861 @default.
- W3138906837 cites W2116932519 @default.
- W3138906837 cites W2119811331 @default.
- W3138906837 cites W2126361876 @default.
- W3138906837 cites W2145817798 @default.
- W3138906837 cites W2149754768 @default.
- W3138906837 cites W2151340435 @default.
- W3138906837 cites W2156118283 @default.
- W3138906837 cites W2158492983 @default.
- W3138906837 cites W2161135181 @default.
- W3138906837 cites W2165421630 @default.
- W3138906837 cites W2315574958 @default.
- W3138906837 cites W2321392740 @default.
- W3138906837 cites W2328214415 @default.
- W3138906837 cites W2346278141 @default.
- W3138906837 cites W2522883401 @default.
- W3138906837 cites W2884137656 @default.
- W3138906837 cites W2909346948 @default.
- W3138906837 cites W2939469066 @default.
- W3138906837 cites W2953619101 @default.
- W3138906837 cites W2978386692 @default.
- W3138906837 cites W2991619365 @default.
- W3138906837 cites W2994243335 @default.
- W3138906837 cites W3000635934 @default.